Detection of prostate cancer and predicting progression: current and future diagnostic markers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
James V TricoliBarbara A Conley

Abstract

Carcinoma of the prostate is the second leading cause of male cancer-related death in the United States. Better indicators of prostate cancer presence and progression are needed to avoid unnecessary treatment, predict disease course, and develop more effective therapy. Numerous molecular markers have been described in human serum, urine, seminal fluid, and histological specimens that exhibit varying capacities to detect prostate cancer and predict disease course. However, to date, few of these markers have been adequately validated for clinical use. The purpose of this review is to examine the current status of these markers in prostate cancer and to assess the diagnostic potential for future markers from identified genes and molecules that display loss, mutation, or alteration in expression between tumor and normal prostate tissues. In this review we cite 91 molecular markers that display some level of correlation with prostate cancer presence, disease progression, cancer recurrence, prediction of response to therapy, and/or disease-free survival. We suggest criteria to consider when selecting a marker for further development as a clinical tool and discuss five examples of markers (chromogranin A, glutathione S-transferase pi ...Continue Reading

References

Dec 22, 1977·The New England Journal of Medicine·A G FotiR R Malvaez
Mar 1, 1992·The Journal of Urology·M K BrawerP H Lange
Mar 1, 1992·The Journal of Urology·F LabrieJ Emond
Apr 25, 1991·The New England Journal of Medicine·W J CatalonaG L Andriole
Apr 1, 1987·The Journal of Urology·P GuinanP Ray
Oct 8, 1987·The New England Journal of Medicine·T A StameyE Redwine
Aug 15, 1989·The Biochemical Journal·J P Simon, D Aunis
Sep 4, 1995·International Journal of Cancer. Journal International Du Cancer·J K TroyerG L Wright
Nov 22, 1994·Proceedings of the National Academy of Sciences of the United States of America·W H LeeW G Nelson
Jun 1, 1994·British Journal of Cancer·R Simon, D G Altman
May 31, 1997·Lancet·J A UríaC López-Otín
Aug 1, 1997·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·B V KallakuryJ S Ross
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·R E ReiterO N Witte
Mar 4, 1998·Journal of Clinical Laboratory Analysis·J T WuR A Stephenson
Jun 4, 1998·Urology·L J Deftos, P A Abrahamsson
Nov 24, 1999·Genes, Chromosomes & Cancer·R E ReiterR B Jenkins
Nov 14, 2000·The Prostate·E CaldareraP L Carmichael
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·D C SaffranA Jakobovits
Apr 18, 2001·International Journal of Cancer. Journal International Du Cancer·A GsurM Micksche
Jul 4, 2001·Pharmacogenetics·Z Kote-JaraiUNKNOWN CRC/BPG UK Familial Prostate Cancer Study Collaborators
Aug 24, 2001·Nature·S M DhanasekaranA M Chinnaiyan

❮ Previous
Next ❯

Citations

Jun 5, 2007·The Journal of Membrane Biology·Mansoor Abdul, Naseema Hoosein
Feb 15, 2008·Cancer Immunology, Immunotherapy : CII·Vafa ShahabiPaulo Maciag
Nov 10, 2011·World Journal of Urology·Luigi MeariniMassimo Porena
Apr 23, 2008·Cancer Metastasis Reviews·Eva ChristensenRobert G Bristow
Aug 3, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Irene Casanova-SalasJose Antonio López-Guerrero
Jun 5, 2013·Indian Journal of Surgical Oncology·Mohan Adhyam, Anish Kumar Gupta
Mar 25, 2010·Journal of the American Chemical Society·Oscar R MirandaVincent M Rotello
Mar 4, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Ida RapaMarco Volante
Jul 30, 2009·Journal of Clinical Pathology·F McCarthyC S Cooper
Nov 18, 2010·Journal of Clinical Pathology·F McCarthyC S Cooper
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carolyn J M BestRodrigo F Chuaqui
Mar 13, 2010·Future Oncology·Giovanni LughezzaniPierre I Karakiewicz
Nov 17, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Suzanne E LapiElla F Jones
Nov 26, 2013·Biomarkers in Medicine·Ailsa Sita-LumsdenCharlotte L Bevan
Feb 15, 2011·Asian Journal of Andrology·Rodrigo LedezmaHéctor R Contreras
Aug 29, 2013·Journal of Ophthalmology·Shawn C MaloneyMiguel N Burnier
Feb 7, 2007·Proceedings of the National Academy of Sciences of the United States of America·V Uma BaiG Prem-Veer Reddy
May 17, 2014·Asian Journal of Andrology·Min QuYing-Hao Sun
Oct 20, 2006·Critical Reviews in Clinical Laboratory Sciences·Qinghua FengNancy B Kiviat
Dec 18, 2009·Expert Review of Molecular Diagnostics·Yongliang Yang SAmin I Kassis
May 18, 2010·Actas urologicas españolas·J Ruiz-Aragón, S Márquez-Peláez
Mar 31, 2009·Critical Reviews in Oncology/hematology·Jingjing YouYong Li
Feb 26, 2008·The Journal of Urology·Ina L DerasJack Groskopf
Dec 2, 2006·Urologic Oncology·Timothy J BradfordArul M Chinnaiyan
Aug 22, 2006·The Prostate·Uta SchmidtAxel Meye
May 3, 2006·The Prostate·Celeste L KremerRaymond B Nagle
Aug 24, 2006·The Prostate·Jianghua WangMichael Ittmann
Apr 19, 2007·The Prostate·Martijn P M Q van GilsJack A Schalken
Feb 8, 2007·The Prostate·Katja AdolfNiels Tørring

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.